About Vercali Pharma Private Limited
Data last updated:
Vercali Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 2019.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC131713. Its GSTIN is 36AAGCV8740H1ZZ (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.97 Lakh. It is led by directors Hemalatha Cherukuneedi and Uday Kishan Cherukuneedi.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No.17 High Tension Main Road Vertex Privilege Nizampet, Hyderabad, Telangana, India – 500085.
As per the financials filed for FY 2021, the company reported a revenue of ₹19.66 Lakh, a decline of 57% compared to the previous year. For the same year it recorded a net loss of ₹10.44 Lakh (net margin -53.1%) and EBITDA of -₹9.44 Lakh (EBITDA margin -48%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The last known website on record is vercalipharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.17 High Tension Main Road Vertex Privilege Nizampet, Hyderabad, Telangana, India – 500085
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vercali Pharma Private Limited
The main business activity of Vercali Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vercali Pharma Private Limited FY 2021 filings available
Vercali Pharma Private Limited reported revenue of ₹19.66 Lakh (down 57% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Vercali Pharma Private Limited
Revenue fell 57% in the latest year. EBITDA rose 42% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Vercali Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹9.44 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹10.44 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Vercali Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -48% | •••• | •••• |
| Net Profit Margin | -53.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vercali Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Vercali Pharma Private Limited
Vercali Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemalatha Cherukuneedi | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
| Uday Kishan Cherukuneedi | Director | 25 Aug 2022 | 4 Years 1 Months | Current |
Peer Comparison of Vercali Pharma Private Limited
Vercali Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Karbon Pharma Private Limited | ₹19.78 Lakh (FY 2025) | •••• | •••• | 343.0% | •••• | Chandigarh, India |
| St. Jude Pharma Private Limited | ₹19.69 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Jammu, Jammu and Kashmir, India |
| Zeotec Life Science Private Limited | ₹19.68 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Ahmedabad, Gujarat, India |
| Ronson Cellulose Private Limited | ₹19.68 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Ahmedabad, Gujarat, India |
| Primoris Healthcare Private Limited | ₹19.67 Lakh (FY 2024) | •••• | •••• | 79.0% | •••• | Jamnagar, Gujarat, India |
| Vercali Pharma Private Limited this company | ₹19.66 Lakh (FY 2021) | •••• | •••• | -57.0% | •••• | Hyderabad, Telangana, India |
| SRV Pharma Private Limited | ₹19.66 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | New Delhi, Delhi, India |
| Fairmount Healthcare Private Limited | ₹19.6 Lakh (FY 2016) | •••• | •••• | 60.0% | •••• | Mumbai, Maharashtra, India |
| Kaymed Pharmaceuticals Private Limited | ₹19.53 Lakh (FY 2025) | •••• | •••• | 106.0% | •••• | New Delhi, Delhi, India |
| Care and Cure Formulations Private Limited | ₹19.51 Lakh (FY 2019) | •••• | •••• | -23.0% | •••• | Chennai, Tamil Nadu, India |
| Bridge Pharmaceuticals Private Limited | ₹19.42 Lakh (FY 2021) | •••• | •••• | -70.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Vercali Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Vercali Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vercali Pharma Private Limited
Vercali Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Vercali Pharma Private Limited
Vercali Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Vercali Pharma Private Limited
Employment history and EPFO contributions of people linked to Vercali Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vercali Pharma Private Limited
Vercali Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Uday Kishan Cherukuneedi ceased to be Additional Director on 17 Nov 2025.
Credit Ratings, Litigation & Regulatory Alerts for Vercali Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vercali Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vercali Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vercali Pharma Private Limited
Vercali Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCV8740H1ZZ | Telangana | Active | 12 Apr 2019 |
| 37AAGCV8740H1ZX | Andhra Pradesh | Active | 23 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vercali Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vercali Pharma Private Limited
Vercali Pharma is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Vercali Pharma is a company pending strike off, currently registered as a private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 2019 and is registered under CIN U24239TG2019PTC131713. The company may be struck off soon - caution is advised.
Vercali Pharma has 2 current directors:
- Hemalatha Cherukuneedi - Director
- Uday Kishan Cherukuneedi - Director
The CIN (Corporate Identification Number) of Vercali Pharma is U24239TG2019PTC131713. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vercali Pharma was incorporated on 29 March 2019. It is registered with the Registrar of Companies, Hyderabad.
Vercali Pharma can be reached through the website vercalipharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Vercali Pharma is at Plot No.17 High Tension Main Road Vertex Privilege Nizampet, Hyderabad, Telangana, India – 500085.
Vercali Pharma reported revenue of ₹19.66 Lakh for FY 2021 (down 57% YoY).
Vercali Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.97 Lakh.
Vercali Pharma reported a net loss of ₹10.44 Lakh (net margin -53.1%) and EBITDA of -₹9.44 Lakh (EBITDA margin -48%) for FY 2021, as per its filed financial statements.
The GSTIN of Vercali Pharma is 36AAGCV8740H1ZZ, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 37AAGCV8740H1ZX (Andhra Pradesh).